dpp 4 inhibitors and glp 1 agonists together Mechanisms of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, glucagon‐like fig2.gif
Description
FDA Fast Track designation
10.1016/j.mce.2010.04.022
By now Holst had joined them as a consultant (Molteni, Chen)
13 More than half of adults taking these medications reported having difficulty affording them
It is also expressed at lower levels in the gut, kidneys, liver, heart, muscle and the PNS (6)
That gap of 10+ percentage points represents a fundamentally different outcome for many individuals
